ENOV · XBRL financial data

Enovis financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ENOV's year ends in late December)

In millions of dollars	Q3 FY23Sep 29, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Apr 4, 2025	Q2 FY25Jul 4, 2025	Q3 FY25Oct 3, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026
Revenue from contracts with customers	418	455*	516	525	505	561*	559	565	549	576*	589	583
Cost of goods and services sold	175	191*	218	236	219	253*	227	230	220	226*	224	224
Gross profit	243	264*	298	289	286	308*	332	335	329	349*	365	359
Research and development	20	18*	23	23	20	24*	29	31	30	31*	32	32
Selling, general and administrative	204	211*	256	264	250	258*	269	267	264	270*	283	264
Other operating income (expense)	1	—	(24)	34	0	—	(1)	0	0	—	3	(2)
Operating income (loss)	(20)	(6)*	(35)	(44)	(32)	(665)*	(47)	(17)	(558)	(502)*	7	17
Interest expense	6	4*	20	17	11	9*	9	9	9	8*	9	8
Other income (expense)	1	25*	(24)	34	0	0*	(1)	0	0	0*	3	(2)
Income tax expense (benefit)	(6)	5*	(7)	(9)	(9)	30*	(2)	11	4	9*	9	9
Net income (loss)	(3)	3*	(72)	(19)	(32)	(703)*	(56)	(37)	(571)	(521)*	(9)	(1)
Earnings per share, basic USD per share	(0.05)	0.05*	(1.32)	(0.34)	(0.58)	(12.59)*	(0.98)	(0.64)	(9.99)	(9.10)*	(0.15)	(0.02)
Earnings per share, diluted USD per share	(0.05)	0.05*	(1.32)	(0.34)	(0.58)	(12.59)*	(0.98)	(0.64)	(9.99)	(9.10)*	(0.15)	(0.02)
Weighted average shares, basic millions of shares	55	55*	55	55	56	56*	57	57	57	57*	57	58
Weighted average shares, diluted millions of shares	55	55*	55	55	56	56*	57	57	57	57*	57	58

Fiscal quarters (ENOV's year ends in late December)

In millions of dollars	Q3 FY23Sep 29, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Apr 4, 2025	Q2 FY25Jul 4, 2025	Q3 FY25Oct 3, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026
Cash and cash equivalents	32	36	66	35	35	48	38	44	34	36	33	13
Accounts receivable	277	291	381	395	400	407	436	454	432	443	444	442
Inventory	471	469	586	615	610	547	586	628	614	584	603	602
Total current assets	854	897	1,151	1,173	1,203	1,146	1,218	1,280	1,280	1,207	1,240	1,215
Property and equipment, net	260	271	346	378	403	405	426	460	486	507	520	528
Right-of-use asset	63	64	70	68	63	69	66	65	73	72	75	75
Goodwill	2,027	2,061	2,415	2,353	2,394	1,693	1,733	1,781	1,219	718	712	710
Total assets	4,401	4,509	5,479	5,442	5,550	4,719	4,875	5,021	4,433	3,835	3,832	3,766
Accounts payable	125	132	156	160	158	179	188	212	199	188	214	194
Accrued liabilities	230	237	373	343	352	330	269	336	355	376	360	380
Current portion of long-term debt	0	0	20	15	20	20	20	20	20	35	35	37
Total current liabilities	355	370	549	518	530	529	477	568	575	598	609	612
Long-term debt	395	466	1,318	1,329	1,325	1,309	1,368	1,374	1,340	1,262	1,291	1,247
Total liabilities	959	1,089	2,168	2,153	2,217	2,154	2,255	2,440	2,410	2,343	2,353	2,287
Retained earnings (accumulated deficit)	540	542	470	452	420	(283)	(339)	(376)	(947)	(1,467)	(1,476)	(1,477)
Total stockholders' equity	3,440	3,418	3,308	3,286	3,330	2,562	2,618	2,578	2,021	1,490	1,477	1,477
Total liabilities and equity	4,401	4,509	5,479	5,442	5,550	4,719	4,875	5,021	4,433	3,835	3,832	3,766
Common shares outstanding (cover page) millions of shares	55	55	55	56	56	57	57	57	57	57	58	58

Fiscal quarters (ENOV's year ends in late December)

In millions of dollars	Q3 FY23Sep 29, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Apr 4, 2025	Q2 FY25Jul 4, 2025	Q3 FY25Oct 3, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Apr 3, 2026	Q2 FY26Jul 3, 2026
Net income (loss)	(3)	3*	(72)	(19)	(32)	(703)*	(56)	(37)	(571)	(521)*	(9)	(1)
Stock-based compensation	9*	8*	1	13*	8*	8*	7	9*	9*	8*	9	9*
Depreciation and amortization	55*	57*	6	133*	71*	717*	71	72*	74*	1,127*	73	71*
Net cash from operating activities	31*	68*	(36)	8*	54*	88*	(2)	48*	83*	89*	24	75*
Purchases of property and equipment	27*	28*	37	39*	51*	53*	43	44*	53*	56*	53	44*
Net cash from investing activities	(17)*	(59)*	(798)	(41)*	(58)*	(58)*	(61)	(50)*	(56)*	(13)*	(53)	(45)*
Proceeds from issuing common stock	—	year only	—	—	—	year only	—	—	—	year only	—	—
Proceeds from issuing equity	0*	—	1	0*	0*	—	0	1*	0*	—	1	0*
Share repurchases	—	year only	—	—	—	year only	—	—	—	year only	—	—
Net cash from financing activities	(14)*	3*	865	3*	(0)*	(20)*	51	6*	(37)*	(73)*	26	(51)*
Net change in cash	(0)*	13*	30	(31)*	(4)*	8*	(10)	6*	(10)*	3*	(3)	(21)*

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Enovis	13	583	75*	57.7M	—	Q2 FY26 10-QJul 3, 2026
Ufp Technologies	9	174	16*	7.7M	—	Q2 FY26 10-QJun 30, 2026
Lemaitre Vascular	27	not reported	16*	22.9M	—	Q2 FY26 10-QJun 30, 2026
Haemonetics	223	339	52	45.5M	—	Q1 FY27 10-QJun 27, 2026
Teleflex	300	570	not reported	42.4M	—	Q2 FY26 10-QJun 30, 2026
AtriCure	168	154	22*	50.9M	—	Q2 FY26 10-QJun 30, 2026
LivaNova	517	391	67*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
Artivion	77	126	(1.3)*	48.8M	61.1 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.